This content is machine translated T2D: Pioglitazone as an add-on to metformin and dapagliflozin Effective strategy for improving blood glucose control Type 2 diabetes (T2D) is a progressive disease characterized by a deterioration in the function of pancreatic β-cells and increased insulin resistance. Although there are many diabetes medications on the…
View Post 3 min This content is machine translated Adolescents with type 1 diabetes Metformin can improve subclinical atherosclerosis Neuregulin-4 (Nrg-4) may have anti-inflammatory and anti-atherogenic properties. Egyptian researchers used Nrg-4 together with carotid intima-media thickness as a marker for subclinical atherosclerosis. Their finding: The addition of metformin to…
View Post 4 min This content is machine translated Post-pancreatitis diabetes Insulin requirement three times as high as for type 2 Post-pancreatitis diabetes mellitus ( PPDM) is a common consequence of chronic pancreatitis (CP). However, patients with PPDM are often misclassified as type 2 diabetics. However, clinically significant complications may be…
View Post 4 min This content is machine translated Modern treatment of type 2 diabetes Combine metformin with new substance classes at an early stage Lifestyle modification alone is usually not sufficient in type 2 diabetes. Metformin is still considered the first-line drug. However, SGED and international professional societies recommend early combination with an SGLT-2…
View Post 5 min This content is machine translated Type 2 diabetes: SGED recommendations update Reduction of cardiovascular complications as top priority Prevention of microvascular and macrovascular complications is an important overarching goal in the management of type 2 diabetes, and the current SGED guidelines have further informed decision making in cardiovascular…
View Post 13 min This content is machine translated Type 2 diabetes Focus on heart & kidney: therapy choice in patients with limiting factors Classes of drugs with different mechanisms of action are available for the treatment of type 2 diabetes. However, the presence of renal or cardiac insufficiency, cardiovascular disease, or insulin deficiency…
View Post 9 min This content is machine translated New antidiabetic agents Combination therapies enable very potent HbA1c reduction Lifestyle modification (exercise, diet) and metformin remain the cornerstones in the treatment of diabetes mellitus type 2. Before initiating antidiabetic therapy, it is recommended to set an individual HbA1c target. Advantages…
View Post 3 min This content is machine translated SGIM Congress in Basel Diabetes update – what do you need to know about the different agents? A lot has happened in the field of diabetes therapy in recent years. Many new active ingredients have appeared on the market. However, metformin and lifestyle modifications are still considered…
View Post 2 min This content is machine translated Cancer patients with diabetes Metformin against cancer? There is increasing evidence from epidemiological studies and scientific research that metformin may have an antitumor effect. However, whether the drug improves survival in cancer patients with diabetes remains unclear…
View Post 4 min This content is machine translated Hype or hope? Metformin, vitamin D and aspirin as anticancer agents Time and again, various substances are praised as “anticancer agents,” both in scientific circles and in the lay press. A symposium at this year’s ASCO Congress in Chicago was dedicated…
View Post 8 min This content is machine translated Insulin in type 2 diabetes When and in which combination? The current therapy guidelines for diabetes mellitus type 2 provide for the use of insulin as initial therapy as well as a later therapy option in monotherapy or in combination with…
